News & Blog

Tag Archives: FDA

Glossary Blog, June 2018: Pivotal Clinical Trial

Pivotal Clinical Trial: A clinical trial or study intended to provide evidence for a new treatment approval by the United States Food & Drug Administration (FDA) This month we take a quick look at term that’s used in the field of biomedical research and drug development, that has both a figurative and an official technical/literal […]

Potential Brain Tumor Treatments Entering the Pivotal Phase of Evaluation – June 2018

A large, randomized, controlled Phase III clinical trial is traditionally the last, pivotal step in the evaluation of a potential new medicine before it is approved for use by all patients with the indicated disease. A year ago, the NBTS staff conducted and published a review of all the Phase III clinical trials for glioblastoma […]

Advice Column, April 2018: Exploring Novel Brain Tumor Treatments

National Brain Tumor Society recently announced the launch of a new patient and care-partner education, empowerment, and preparedness effort. The new initiative will provide the resources, information, tools, and guidance brain tumor patients and their care-partners need to play a more active role in their treatment planning and decision-making. As part of the broader effort to […]

Share